Introduction
Arsenic is an environmental toxin but has also been used as a therapeutic agent for more than 2,400 years. In the 1930s, patients with chronic myelogenous leukemia were treated with arsenic and the use of arsenic in leukemia resurfaced when reports from China provided evidence that arsenic induced remissions in acute promyelocytic leukemia (APL). 1, 2 Subsequently the efficacy of arsenic trioxide (As 2 O 3 ) in the treatment of APL was confirmed in randomized clinical trials. 3, 4 Currently clinical trials are testing arsenic in the treatment of other hematologic malignancies including lymphoma and myeloma, (for a review see). 5 Arsenic appears to exert its effects on tumor cells by several mechanisms. [6] [7] [8] [9] The activity of arsenic in APL is in part due to degradation of the oncoprotein PML-RAR , and induction of differentiation. 2, [10] [11] [12] The therapeutic effects of arsenic are also dependent on its ability to induce growth inhibition, cell cycle arrest and activation of apoptotic pathways. Some of the apoptotic effects of arsenic are attributed to its ability to cause the collapse of the inner mitochondria transmebrane potential and release of cytochrome C, [13] [14] [15] [16] the down regulation of Bcl-2 12,17 and the activation of caspaces which ultimately lead to cell death. [17] [18] [19] Numerous studies indicate that arsenic induces the generation of reactive oxygen species (ROS) that contribute significantly to cell killing. 14, 15, 20 Antioxidant molecules such as glutathione (GSH) reduce the cytotoxic effects of arsenic largely by quenching ROS [21] [22] [23] [24] and cells containing low levels of GSH are more sensitive to arsenic. 24 Catalase suppresses arsenic-induced apoptosis. 13 These observations suggest that down-regulating antioxidant molecules, or the biochemical pathways that generate them, could be therapeutically useful in altering the cytotoxicity only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013 . bloodjournal.hematologylibrary.org From of arsenic. Paradoxically, vitamin C, a key antioxidant molecule, [25] [26] [27] was reported to augment the toxicity of arsenic in vitro. 24, [28] [29] [30] [31] These studies suggested that the prooxidant properties of vitamin C in vitro increase ROS that enhance the cytotoxicity of arsenic. 24, 28 Based on these reports, clinical trials have been designed to test the use of vitamin C to augment arsenic activity in the treatment of myeloma. 32 Recent studies in rats using sodium arsenite, however, indicate that vitamin C ameliorated arsenic induced toxicity. [33] [34] [35] [36] The pro-oxidant characteristics of vitamin C in vitro are well documented and the generation of ROS by ascorbic acid (AA) in vitro is dependent on free transition metal ions, such as iron and copper, in tissue culture media. 26, 37 There is little evidence that free transition metals are available in vivo to enable the reactions by which AA can produce ROS in vitro. 26, 27, 37 In vivo, iron and copper are generally sequestered by transition metal binding proteins, including ferritin, transferrin, lactoferrin and caeruloplasmin. 26, 38 The production of ROS by AA in vitro is believed to be largely a tissue culture phenomenon. 26, 37 In the studies that reported an increase in arsenic cytotoxicity with vitamin C, AA was directly added to the tissue culture media. 24, [28] [29] [30] [31] There are two known mechanisms that cells use to transport and accumulate vitamin C. All cells transport dehydroascorbic acid (DHA), the oxidized form of vitamin C, via the facilitative glucose transporters. 39, 40 The reduced form of vitamin C, ascorbic acid (AA), is transported by sodium dependent ascorbic acid transporters 41 which are widely expressed at the mRNA level, however, only specialized cells appear to transport AA directly. [42] [43] [44] Sodium dependent transport is critical for development as shown by only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From knockout studies. 45 Most cells appear to rely on ascorbic acid oxidation to DHA for the transport and accumulation of vitamin C. [46] [47] [48] To circumvent the in vitro pro-oxidant properties of AA, we loaded HL60 myeloid leukemia cells, U266 and RPMI-8226 myeloma cells with vitamin C using DHA and then tested their response to arsenic. HL60 and U266 cell lines were used previously and reported to be sensitized to arsenic toxicity with vitamin C. 24, 28 Contrary to those findings, we found that intracellular vitamin C protected these cancer cells from arsenic cytotoxicity.
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Materials and Methods

Reagents and cell lines
HL60 were obtained from American Type Culture Collection (ATCC) and maintained in IMDM. U266 and RPMI-8226 were maintained in RPMI, suplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/mL penicillin and 100 µg/mL streptomycin in an atmosphere of 5% CO 2 at 37 °C. The cells used in the experiments were in the logarithmic phase of growth and their viability was greater than 90%. Cell viability was determined by trypan blue exclusion. Ascorbic acid (AA), N-acetyl-L -cysteine (NAC), SDS and counted by liquid scintillation spectrometry to determine the cell associated radioactivity. Cell volume and cell associated radioactivity were used to estimate the intracellular concentration of vitamin C.
Cell volume determination
Cell volume was estimated as described previously with 30% correction for trapping extracellular radioactivity. 39 
Depletion of glutathione
Cells were depleted of glutathione as previously described. 50 Briefly, 3 x 10 5 cells/mL were incubated with 0.2 mM DL-buthionine-sulfoximine (BSO) for 16 hours, followed by 1 hour incubation with 1 mM diethyl maleate and washing in PBS.
Treatment of cells with of As 2 O 3
As 2 O 3 was prepared as a 0.5 mM stock solution in PBS and stored at room temperature in the dark. Cells were treated with different concentrations of As 2 O 3 for the time indicated and cell viability was determined by trypan blue exclusion 24 or 48 hours after treatment.
Cells were washed in PBS prior to plating in methylcellulose to remove excess As 2 O 3 and colonies were counted as indicated in the figure legends.
Methylcellulose colony assays
MethoCult was prepared according to the manufacturer's instructions containing 1% methylcellulose, 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/mL penicillin and 100 µg/mL streptomycin in IMDM. Methylcellulose was dispensed into tubes using a 16 gauge blunt needle, 3 mL/tube. Cells treated under different conditions with vitamin C 
Plasma isolation
With appropriate informed consent, peripheral blood was obtained from a healthy 
Detection of apoptosis
Apoptotic cells were labeled using a TUNEL (TdT-mediated dUTP nick end labeling) assay according to the manufacturers instructions. Positively TUNEL stained cells were counted using a fluorescent microscope. The Annexin V-FITC/propidium iodine (PI) apoptosis detection kit (Pharmigen, San Diego, CA) was also used to determine the frequency of apoptosis in HL60 cells using flow cytometry analysis.
Statistical analyses
Data are presented graphically as the mean +/-standard deviation (SD). Statistical analysis was done using Sigmaplot software (Jandel Scientific, Chicago, IL). For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From was added for 10 min. The accumulation of vitamin C decreased with increasing concentrations of cytochalasin B reaching 50% inhibition at approximately 0.2 µM and complete inhibition at 10 µM. Cytochalasin E, a structurally similar molecule was used as a control and had no effect on the transport of 14 C labeled DHA (Fig. 1C) . (Fig. 2D) . There was no colony formation in cells treated with higher concentrations of As 2 O 3 .
Vitamin C protects HL60, U266 and RPMI-8226 cells from As 2 O 3 cytotoxicity
We tested the effect of vitamin C on As 3A ). Vitamin C loading also protected U266 cells from the toxicity of 1 µM As 2 O 3 ( Fig.   3D ). Maximum cell protection was achieved at 3 mM intracellular vitamin C with a 1-fold increase in viability. In both cell lines, higher concentrations of vitamin C did not increase protection from arsenic toxicity (Fig. 3A, D) . Vitamin C loading also protected U266 and HL60 cells from arsenic toxicity as measured by the capacity to proliferate and only.
For (Fig. 3B, E) . U266 and HL60 cells were maximally protected from 1 and 2 µM As 2 O 3 with 4 and 2 mM intracellular vitamin, respectively (Fig. 3B, E) . We found that 4 mM intracellular AA inhibited arsenic-induced apoptosis in HL60 cells as measured by Annexin V/FITC assay. Using this assay, cells treated with As 2 O 3 showed approximately a 7-fold increase in apoptosis (Fig. 3C, left panel) .
Additionally, As 2 O 3 induced a 6-fold increase in apoptosis in HL60 using a TUNEL assay, while, cells loaded with 4 mM vitamin C and treated with 3 µM As 2 O 3 were almost completely protected as compared to cells treated with As 2 O 3 alone (Fig. 3C, right panel). The myeloma cell line RPMI-8226 also showed amelioration of cytotoxicity by vitamin C loading. DHA treatment had no effect on RPMI-8226 cell viability (Fig. 3F ).
RPMI-8226 cells incubated with 1 µM As 2 O 3 had 46% viability while cells loaded with 4 mM AA showed 62% viability (Fig. 3F ).
Vitamin C protects GSH depleted cells from As 2 O 3 toxicity.
Although the importance of GSH for the survival of As 2 O 3 treated cells has been described previously, the ability of vitamin C to rescue these cells and replace GSH as an antioxidant has not been delineated. We depleted GSH from the cell lines and loaded them with vitamin C before As 2 O 3 treatment. Depletion of GSH had no significant effect on cell viability; however, depletion of GSH from HL 60 and U266 cells increased their susceptibility to As 2 O 3 toxicity (Fig. 4A) . The viability of HL60 cells treated with 1 and 2 µM As 2 O 3 decreased from 80 and 60% to approximately 20 and 5% respectively (Fig.   4A) . Similarly, the viability of U266 cells treated with 1 and 2 µM As 2 O 3 declined from 40 and 25% to 20 and 3%, respectively in GSH depleted cells (Fig. 4A) .
depleted of GSH and loaded with vitamin C using DHA became more resistant to As 2 O 3 .
Increasing concentrations of vitamin C improved cell survival and provided protection in a concentration dependent manner. Maximum protection was seen at approximately 6 mM intracellular vitamin C and higher concentrations of intracellular vitamin C did not improve the level of protection (Fig. 4B) . Clonogenicity studies confirmed the above observations. GSH depleted HL60 cells loaded with vitamin C and treated with As 2 O 3 produced substantially more colonies as compared to cells treated with As 2 O 3 alone.
Optimal protection was found in cells containing 4 mM intracellular vitamin C, a 2-fold difference as compared to the control. There was no increase in clonogenicity with higher concentrations of vitamin C (Fig. 4C) . Comparable results were obtained with U266 cells (Fig. 4D, E) . GSH deprived cells were more resistant to As 2 O 3 when they contained vitamin C. Cell viability was 1.5-fold higher in U266 cells containing 6 mM intracellular vitamin C and treated with 1 µM As 2 O 3 as compared to cells treated with As 2 O 3 alone (Fig. 4D) . Also, an approximately 2-fold increase in colony forming capacity was seen in cells containing 4 mM intracellular vitamin C and treated with 1 µM As 2 O 3 , as compared to cells treated with As 2 O 3 alone (Fig. 4E) . Another antioxidant N-acetyl cysteine (NAC), which may act to increase the intracellular concentration of GSH in cells, protected HL60 cells from the cytotoxicity of As 2 O 3 (Fig. 4F) . Incubation of cells with 2.5, 5, 10, and 15 mM of NAC provided increasing protection and 10 mM NAC completely abrogated the toxicity of 3 µM As 2 O 3 (Fig. 4F) .
Extracellulular vitamin C increases the toxicity of As 2 O 3 in vitro by generating ROS
As reported by others, 24 ,28 the addition of ascorbic acid to cell cultures increased the toxicity of As 2 O 3 (Fig. 5) . The viability of HL60 and U266 cells decreased when cells were treated with 100 µM AA and As 2 O 3 , as compared to cells treated with As 2 O 3 alone (Fig. 5A, B) . The viability of HL60 and U266 cells declined from 80% to 57% and 50%
to 30%, respectively in cells treated with 100 µM AA and 1 µM As 2 O 3 , as compared to cells treated with As 2 O 3 alone (Fig. 5A, B) . A comparable decrease in cell viability was detected in cells treated with 100 µM AA and 2, 3 and 5 µM As 2 O 3 . Addition of DTT to cell cultures incubated with AA did not change the cell viability (data not shown). We found that cells pretreated with DHA accumulate AA that protects against As 2 O 3 -induced cytotoxicity. To determine the effect of DHA when incubated in the media as for the AA treatments, HL60 cells were incubated for 20 hours with 1 mM DHA or AA and apoptosis was measured using annexin V/FITC assay (Fig. 5C ). DHA treatment did not induce apoptosis, however, AA at the same concentration resulted in a 40% increase in apoptosis (Fig. 5C, right panel) . Additionally, we found that DHA in the media incubated simultaneously with As 2 O 3 did not enhance the cytotoxicity of As 2 O 3 ( Figure   5C , right panel).
AA is known to generate ROS in culture media without cells 37 and high concentrations of AA generate quantities of ROS that can kill cells in the absence of other agents. We examined the independent toxicity of AA by incubating HL60 cells with AA and assessing cell viability 48 hours post-treatment. There were no detectable changes in cell viability in cells treated directly with AA up to 0.5 mM AA (Fig. 5D ).
Higher concentrations of AA (2.5 and 5 mM), reduced cell viability to approximately 60 only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From and 40%, respectively. At very high concentrations of AA (10 and 20 mM) the entire population of cells was killed (Fig. 5D) . Decreasing the antioxidant capacity of the cells by depleting intracellular GSH, greatly sensitized HL60 cells to the oxidative stress generated by extracellular AA in culture media (Fig. 5D) . The viability of GSH depleted HL60 cells treated with 0.05 and 0.1 mM AA for 48 hours was reduced to 80 and 70%, respectively. In cells treated with 1 mM AA the viability was reduced to zero as compared to 90% viability in cells containing GSH (Fig. 5D ). These studies indicate that GSH protects cells from ROS generated by AA in vitro and cells containing low levels of GSH are more susceptible to ROS generated by AA in the culture media.
We measured intracellular accumulation of ROS in order to explain the difference in survival seen in cells treated with AA or loaded with vitamin C using DHA (Fig. 5E ).
HL60 cells were incubated with DHA for 60 min and ROS was measured as described. (Fig. 6A) . Comparable concentrations of DHA did not generate any H 2 O 2 , identical to the control media alone (Fig. 6A) . The addition of 500 U/mL catalase resulted in a reduction of H 2 O 2 generated by 1.0 mM AA, from about 25 µM to 4 µM (Fig. 6B) . Similar results were obtained when H 2 O 2 was added to IMDM containing 500 U/mL catalase (Fig. 6B) . We then tested if the generation of H 2 O 2 in cell free media by AA was dependent on the presence of free transition metal ions in the culture media. IMDM containing 100 µM AA was incubated with increasing concentrations of the transition metal chelator 2,3-dimercaptopropanol (DMP) for 1 hour at 37 °C and H 2 O 2 generation quantified. In the absence of DMP, 100 µM AA generated about 7 µM H 2 O 2 and increasing concentrations of DMP reduced the amount of H 2 O 2 produced (Fig. 6C) . In media containing 0.1, 1.0 and 10.0 mM DMP the concentration of H 2 O 2 generated was approximately 5, 2,5 and 0.5 µM, respectively (Fig. 6C) . DMP also reduced the amount of H 2 O 2 generated in association with the addition of copper, a transition metal ion that interacts with AA to generate H 2 O 2 . Incubation of 10 µM CuCl 2 and 100 µM AA generated about 13 µM H 2 O 2 and in the presence of 1.0 mM DMP the concentration of H 2 O 2 was reduced to 3 µM (Fig. 6C) (Fig. 6D) . The addition of catalase partially inhibited the cytotoxic effect of AA and As 2 O 3 in HL60 cells (approximately a 20%, data not shown).
AA does not generate H 2 O 2 in human plasma
We sought to approximate the in vivo circumstance by testing if adding AA to human plasma led to the generation of H 2 O 2 . AA up to 1 mM was incubated in plasma for 1 hour and H 2 O 2 was quantified. We did not detect significant H 2 O 2 production by AA in plasma (Fig. 7A) . AA generated H 2 O 2 only in tissue culture media (Fig. 7A, last   bar) . Addition of 100 µM of CuCl 2 to human plasma was required to approximate the AA dependent generation of H 2 O 2 in IMDM (Fig. 7B) . only.
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Consequently, the pro-oxidant and cytotoxic properties of AA in vitro are thought to be an in vitro artifact. 37, 63, 64 To circumvent the in vitro pro-oxidant effects of AA, we loaded HL60 and U266 cells (which do not transport AA directly) with vitamin C by incubating them with DHA. [68] [69] [70] Cells loaded with vitamin C were significantly protected from As 2 O 3 toxicity.
Increasing concentrations of intracellular vitamin C in HL60, U266 and RPMI-8226 cells provided increasing protection from As 2 O 3 cytotoxicity with maximum protection achieved at 2-8 mM intracellular AA. GSH depleted cells showed the expected increased sensitivity to As 2 O 3 and vitamin C loading protected these cells from As 2 O 3 cytotoxicity even more prominently. In previous studies we showed that GSH depleted cells were sensitized to the cytotoxic effect of H 2 O 2 and cells loaded with vitamin C were protected. 70 The protection of HL60 and U266 cells from the toxicity of As 2 O 3 by DHA loading, was likely due to the marked reduction of intracellular ROS. Treating cells directly with AA prominently increased intracellular ROS and high concentrations of AA were quite cytotoxic on themselves with an IC 50 of 5 mM. The cytotoxicity of AA was greatly enhanced when GSH was depleted and the IC 50 was reduced from 5 to 0.5 mM.
H 2 O 2 is a major ROS product generated in vitro by AA and evidence suggested that the enhancement of arsenic's toxicity by AA is partly H 2 O 2 dependent, as killing in cells cotreated with As 2 O 3 and AA is inhibited in the presence of catalase. 24 We confirmed that AA causes the generation of H 2 O 2 in cell-free tissue culture media with 25 µM H 2 O 2 generated at 1 mM AA in 1 hour at 37 °C. Unlike AA, DHA did not stimulate the production of H 2 O 2 in tissue culture media. Chelators of free transition metal ions only.
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To approximate in vivo conditions, we performed experiments to determine if AA generated H 2 O 2 in human plasma. Concentrations of AA as high as 1 mM resulted in no measurable H 2 O 2 generation. These results are consistent with the observation that adding increasing amounts of human serum or plasma to in vitro cultured cells reduces the cytotoxicity of AA, presumably by sequestering free transition metal ions. 60, 61, 71 Recently it was shown that AA does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to both transition metal ions and H 2 O 2 . 72 There is little evidence that vitamin C acts as a pro-oxidant in vivo largely because transition metals in plasma and tissues are sequestered by metal binding proteins, such as transferrin and caeruloplasmin, and are not available to generate free radicals. 26, 27, 63, 64, 73, 74 In vivo, vitamin C has been
shown to function as a strong antioxidant even in the presence of an iron overload. [75] [76] [77] Intracellular signal transduction is often ROS dependent and antioxidants are known to inhibit signaling. 78 For example, vitamin C inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) responses 53 and NF B activation. 79 We found that vitamin C inhibits NF B activation prior to I B kinase activation 79 . Inhibition of NF B by vitamin C could enhance cellular apoptosis. The notion that AA will increase the therapeutic effect of As 2 O 3 in the treatment of myeloma is currently being tested in clinical trials. 32 These studies are based on the hypothesis that AA could enhance the therapeutic efficacy of As 2 O 3 by a mechanism similar to the one shown in vitro, in which AA was cytotoxic and decreased the intracellular concentration of GSH. Although, the authors believe that their data shows that AA decrease GSH levels in mononuclear cells, only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From the GSH levels were not consistently lowered nor was it clear that the effect was not due to As 2 O 3 . Evidence from studies in vivo, indicated that vitamin C and GSH have functional interchangeability, sparing each other in antioxidant defense 25, 57 More importantly, a direct study in humans indicated that AA increased GSH levels in lymphocytes. 80 In vivo animal experiments have not shown that combination of vitamin C and As 2 O 3 leads to increased tumor responses. Recher and co-workers found that AA administration did not enhance the effect of As 2 O 3 in a T-cell prolymphocytic leukemia model in mice. 31 Also, the data in a P338D 1 lymphoma model 24 do not appear statistically compelling. In those experiments, As 2 O 3 itself did not increase survival. 24 Other studies in rats indicate that vitamin C ameliorated sodium arsenite induced toxicity. [33] [34] [35] [36] Similarly, vitamin E inhibits arsenic cytotoxicity in vitro and in vivo. 33, 35, 81 The pro-oxidant effects of AA in vitro and the wide belief in potential anti-tumor effects of vitamin C have lead to confusion regarding antioxidants in cancer therapy.
While vitamin C can effect many signaling events in cells, 53, 79 it undoubtedly functions as a strong antioxidant. We provided evidence that vitamin C can decrease oxidative induced mutations 52 and we and others have shown that vitamin C can protect cells from H 2 O 2 and radiation. [68] [69] [70] The evidence presented here indicates that increasing intracellular concentrations of vitamin C ameliorates the cytotoxicity of As 2 O 3 , likely by quenching ROS generated intracellularly. These results suggest that AA is not likely to increase the antineoplastic activity of arsenic, but could provide protection to both normal and neoplastic cells.
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